Matching Analysis of Local and National Recommended Catalogues for TCM Advantageous Diseases and Reflections on Accelerating Implementation

China Health Insurance ›› 2026, Vol. 0 ›› Issue (6) : 95-101.

China Health Insurance ›› 2026, Vol. 0 ›› Issue (6) : 95-101. DOI: 10.19546/j.issn.1674-3830.2026.6.011
Management Platform

Matching Analysis of Local and National Recommended Catalogues for TCM Advantageous Diseases and Reflections on Accelerating Implementation

Author information +
History +

Abstract

This paper conducts a matching analysis on the local catalogs of Traditional Chinese Medicine (TCM) dominant diseases from 15 provinces and prefecture-level cities and the national recommended catalog. The results show that a total of 38 diseases are matched between the local catalogs and the national one, which are mainly distributed in orthopedics, internal medicine and surgery. In addition, several TCM dominant diseases exclusive to certain regions are included in local catalogs. It is suggested to promote the orderly alignment between local and national catalogs, establish a dynamic catalog adjustment mechanism, carry out phased implementation in light of regional conditions, and formulate differentiated implementation strategies, so as to accelerate the implementation of case-based payment for dominant diseases of TCM.

Key words

traditional chinese medicine dominant diseases / case-based payment / matching analysis / catalog alignment

Cite this article

Download Citations
Matching Analysis of Local and National Recommended Catalogues for TCM Advantageous Diseases and Reflections on Accelerating Implementation[J]. China Health Insurance. 2026, 0(6): 95-101 https://doi.org/10.19546/j.issn.1674-3830.2026.6.011

References

[1] 国家中医药管理局综合司,国家医疗保障局办公室.关于印发适宜按病种付费的中医优势病种推荐目录的通知:国中医药综结合函〔2025〕255号[EB/OL].(2025-11-25)[2026-05-05].http://www.natcm.gov.cn/zxyjhyssmzyys/zhengcewenjian/2025-11-25/37314.html.
[2] 国家医保局办公室,国家中医药局综合司.关于开展中医优势病种按病种付试点工作的通知[EB/OL].(2025-10-8)[2026-05-05].https://www.gov.cn/zhengce/zhengceku/202510/content_7043780.htm.
[3] 武泽鑫,张立强,应亚珍.中医优势病种纳入DRG/DIP付费规范分析[J].中国医疗保险,2024(05):35-40.
[4] 王文雅,胡晶,赵晖,等.中医优势病种的中、西医疾病名称与编码特征分析[J/OL].中国实验方剂学杂志,1-11[2026-05-25].https://doi.org/10.13422/j.cnki.syfjx.20261293.
[5] 余丽妹,卢丽鹏,汪丽蓉.中医优势病种分布与管理思考[J].中医药管理杂志,2023,31(06):55-57.
[6] 于伟,李佳宁,钟璐,等.中医优势病种按疗效价值付费改革效果分析[J].卫生经济研究,2025,42(04):23-27.
[7] 李希,邓世虎,彭美华,等.中医优势病种DRG付费:政策、难点及对策[J].卫生经济研究,2025,42(01):39-42.

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉